Dr. Jane Lowe Meisel, MD

Dr. Meisel practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Meisel's NPI, 1831358076, was assigned on June 3, 2008. Dr. Meisel graduated from Harvard Medical School in 2008. Dr. Meisel holds Massachusetts license 242890.

Dr. Meisel's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Meisel's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Meisel is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Meisel to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meisel practices, 6 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Meisel's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Meisel is licensed in Massachusetts.

CMS data shows 285 Medicare services from Dr. Meisel across 3 procedure codes in 2024, all of them office visits, for 168 Medicare patients. Medicare paid $18,309 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Meisel in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have cancer, and 60% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meisel's median patient age at 68, with 96% women.

In 2024, Dr. Meisel wrote 1,355 Medicare Part D claims for 201 patients. 83% of them were for generic drugs. CMS names the drug for 1,043 of them, across 28 drugs with 11 or more claims each, at $1,899,244 in total drug cost. In 2023, CMS named 1,011 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Meisel for performance year 2024, reported through an alternative payment model (APM). Dr. Meisel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meisel as offering telehealth.

Dmand AI links Dr. Meisel to 1 clinical trial. Open Payments lists research payments to Dr. Meisel that name 1 trial.

CMS Open Payments shows 96 general payments to Dr. Meisel from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $28,325. It also lists 1 research payment totaling $832 in 2017, naming 1 clinical trial.

Dr. Meisel graduated from Harvard Medical School in 2008.